CV Sciences, Inc. Announces Silver Level Sponsorship of the 15th Annual Nutrition and Health Conference in Boston, Massachusetts - April 29-May 2, 2018
April 18, 2018 08:45 ET
|
CV Sciences, Inc.
Company Continues its Expansion into the Healthcare Professional Market through One-on-One Education, Exclusive Product Offerings and Enhanced Practitioner Support. LAS VEGAS, April 18, 2018 (GLOBE...
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
April 04, 2018 08:45 ET
|
CV Sciences, Inc.
Company Further Reduces Debt and Avoids Dilution to Stockholders LAS VEGAS, April 04, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”)...
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
March 06, 2018 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, March 06, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the February and March 2018 installment...
CV Sciences, Inc. to Present at the 30th Annual ROTH Conference in Dana Point, California, March 11-14, 2018
February 28, 2018 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Feb. 28, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI), preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, announced today that it...
CV Sciences, Inc. to Exhibit and Present at the 2018 Integrative Health Symposium Annual Conference in New York, New York – February 22-24, 2018
January 24, 2018 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Jan. 24, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), today announced that it will be exhibiting its industry-dominating brand of...
CV Sciences, Inc. to Present at the Biotech Showcase™ 2018
January 03, 2018 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Jan. 03, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent supplier and manufacturer of hemp-derived phytocannabinoids,...
CV Sciences, Inc. to Exhibit at the 25th Annual World Congress on Anti-Aging Medicine in Las Vegas, NV - December 14-16th, 2017
December 12, 2017 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Dec. 12, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), today announced that it will be exhibiting at the 25th Annual World...
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
December 05, 2017 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Dec. 05, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the December 2017 installment obligation...
CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL - December 1-3, 2017
November 21, 2017 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Nov. 21, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL - December 1-3, 2017 Company enters its 3rd year exhibiting its...
CV Sciences, Inc. Named One of North America’s Fastest Growing Companies on Deloitte’s 2017 Technology Fast 500™
November 14, 2017 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Nov. 14, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil and developer of specialty...